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Objectives. We sought to compare the short- and long-term
mortality rates in patients >270 years old with unstable angina
undergoing percutaneous transluminal coronary angioplasty
(PTCA) with predicted coronary artery bypass graft surgery
(CABG) short-term and U.S. census long-term mortality rates.
Background. Coronary angioplasty is an alternative revascu-
larization strategy for patients with medically refractory rest
angina and a high risk of adverse outcomes with CABG. Patients
>270 years old are a specific high risk subset.
Methods. A total of 131 consecutive patients aged >270 years
with unstable angina underwent PTCA; 82 (62%) of 131 had been
refused CABG. Mortality over time was obtained from the Veter-
ans Affairs Beneficiary Index Records Locator Subsystem. Pre-
dicted 30-day CABG-associated mortality was obtained from the
Veterans Affairs Cardiac Risk Assessment Model. Mortality over
time was expressed with Kaplan-Meier curves.
Results. The observed 30-day angioplasty survival rate was 87%
compared with the predicted surgical 30-day survival rate of
85.5%. In those patients who survived 6 months after angioplasty
(84%), their subsequent 1-, 2-, 3-, 4- and 5-year survival rates were
comparable to age-matched subjects in the U.S. census. Mortality
in certain subsets known to be at very high risk for CABG—for
example, patients who had a previous CABG—was not high in this
cohort of elderly subjects. The extremely high risk subsets iden-
tified in this PTCA cohort (shock, heart failure, pressors required,
balloon pump required) were relatively infrequent subsets.
Conclusions. For selected elderly patients with unstable angina
deemed to be at “high risk” or even “prohibitive risk” for CABG,
PTCA is an alternative revascularization strategy. The long-term
mortality of successfully treated elderly patients is comparable to
age-matched subjects. A prospective, multicenter, randomized
trial of CABG versus PTCA, which includes patients >270 years
old, is being conducted (Veterans Affairs Cooperative Study 385:
AWESOME).
(J Am Coll Cardiol 1997;29:339–44)
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Unsuccessful revascularization and adverse outcomes are
more frequent with either coronary artery bypass graft surgery
(CABG) or percutaneous transluminal coronary angioplasty
(PTCA) for patients .70 years of age compared with younger
patients (1–34). Furthermore, because the prevalence of symp-
tomatic coronary artery disease increases with age and because
the U.S. population is aging, both CABG and PTCA proce-
dures are being used in larger numbers in patients.70 years of
age (1). Many patients undergoing CABG or PTCA have
additional clinical risk factors, such as acute infarction, or
anatomic risk factors, such as diffuse disease, which are
associated with even higher rates of adverse outcomes and
mortality (35–42). Despite these facts, recent data suggest that
outcomes using these two procedures are improving over time
(1). This report analyzes survival based on a single center’s
retrospective, consecutive case review of PTCA used to treat
unstable angina in patients$70 years old and identifies clinical
and angiographic predictors of procedural mortality. Short-
term (30 days) mortality with PTCA is compared with pre-
dicted surgical mortality, and long-term (1 to 5 years) mortality
is compared with U.S. census figures. These data are used to
extend the hypothesis that PTCA provides an alternative
revascularization strategy for unstable ischemia patients who
are at “high risk” or “prohibitive risk” for CABG-associated
mortality (35,36), specifically the elderly subset. This hypoth-
esis is being tested prospectively in a 14-center Veterans
Affairs cooperative trial of PTCA versus CABG, which in-
cludes patients $70 years of age (AWESOME).
Methods
The catheterization records of patients undergoing PTCA
between January 1987 and December 1994 were reviewed to
identify all patients $70 years of age. Indications for the
procedure were reviewed to identify all patients with unstable
angina. The study group consists of the 131 patients (12.8% of
total PTCAs performed during this period) meeting these two
criteria. Records were further reviewed to identify the pres-
ence of remote myocardial infarction or recent (within past 7
days) infarction; whether the patient came to the laboratory
while taking digoxin, diuretics or intravenous nitroglycerin or
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with an intra-aortic balloon pump; whether the patient had a
previous CABG; left ventricular ejection fraction; the presence
of heart failure or shock; creatinine; the presence of chronic
obstructive pulmonary disease; cardiomegaly on chest X-ray
film; the presence of peripheral vascular disease; rest electro-
cardiographic (ECG) changes with pain; anginal functional
class; American Society of Anesthesia functional class; and
PTCA priority (elective, urgent or emergent). In this report
and all previous reports from our institution, we use the term
“salvage angioplasty” to mean PTCA that was undertaken in
an attempt to relieve “medically refractory” rest angina in a
patient who was refused CABG by our cardiac surgeons based
on their perception of “prohibitive risk” of CABG-associated
operative mortality (39,40). Patients may also be refused
CABG based on the perception of minimal gain from CABG
relative to its risk. “High risk” for CABG is based on a greater
than twofold increase over baseline in operative mortality
and/or a univariate risk .7% in 30-day CABG mortality, as
ascertained in the 45-hospital VA Surgical Registry data (15).
Defined in this manner, “high risk” does not include the
contributions to CABG risk of diffuse coronary artery disease
or poor distal targets for CABG or the contributions of a
number of significant comorbidities such as liver disease or
cancer. For patients who are refused CABG and those classi-
fied as “high risk” but not refused CABG patients, PTCA was
performed without surgical standby. Hospital records were
reviewed to determine hospital discharge versus in-hospital
mortality. Data on postoperative deaths were also obtained
from the Beneficiary Identification Records Locator System
file (36).
Using the Veterans Affairs Risk Assessment for Cardiac
Surgery multivariate logistic regression analysis of 12 variables,
a predicted 30-day operative mortality was calculated (15). The
12 variables used in this analysis are age, serum creatinine,
history of chronic obstructive pulmonary disease, cardiomeg-
aly, previous heart surgery, peripheral vascular disease, rest ST
segment changes on ECG, angina functional class, preproce-
dure intra-aortic balloon pump, current digoxin use, American
Society of Anesthesia functional class and procedural priority
(elective, urgent or emergent).
Results
Preprocedural variables. As shown in Table 1, all 131
patients in this series were $70 years old and had unstable
angina—66% had rest angina, 40% demonstrated reversible
ECG changes and 16% had a left ventricular ejection fraction
#0.35. Additional risk factors for adverse outcomes with
CABG, as identified in the Veterans Affairs Cardiac Surgery
Risk Assessment program are as listed in Table 1.
Significant comorbidities included chronic obstructive pul-
monary disease (forced expiratory volume in 1 s ,1.5 liter or
home oxygen dependent, or both) in 11%; peripheral vascular
disease (after the operation) in 10%; cerebrovascular disease
(previous stroke or surgical procedure, or both) in 8%; renal
failure (creatinine .2.0 mg/dl or dialysis required, or both) in
6%; and diabetes (insulin-requiring and end-organ damage) in
18%.
Angiographic variables predictive of adverse outcomes with
PTCA included angiographic thrombus in 34 (20%) of 174
vessels, length of diseased segment .2 cm in 50 (29%) of 174
vessels, and occlusion in 27 (16%) of 174 vessels.
Using the latest Veterans Affairs Cardiac Surgical Risk
Assessment Model, the mean predicted CABG 30-day mortal-
ity rate for these patients was 14%, comparable to the observed
30-day PTCA mortality rate of 13%.
Procedural variables. As shown in Table 2, PTCA was
attempted in 174 vessels: 90 patients had single-vessel PTCA,
39 patients had two-vessel PTCA attempted (78) and 2 patients
had three-vessel PTCA attempted (6). The distribution of
vessels is listed in Table 2. Reduction of lesion stenosis to
,50% was accomplished in 150 vessels (86%).
Short-term clinical outcomes are listed in Table 3. All
in-hospital deaths are included in the failure category, al-
though five patients who died during the index hospital period
Abbreviations and Acronyms
CABG 5 coronary artery bypass graft surgery
ECG 5 electrocardiogram, electrocardiographic
PTCA 5 percutaneous transluminal coronary angioplasty
Table 1. Clinical Characteristics of 131 Study Patients
Unstable angina 131 (100%)
Rest angina 87 (66%)
Reversible ECG changes 52 (40%)
MI within 7 days 54 (41%)
Preprocedure heart failure 15 (11%)
Preprocedure shock 6 (5%)
LVEF #0.35 16/100 measured
3-vessel disease 61 (47%)
Prior CABG 57 (44%)
COPD 14 (11%)
Peripheral vascular disease 13 (10%)
Cerebrovascular disease 10 (8%)
Creatinine .2.0 mg/dl 8 (6%)
Diabetes 23 (18%)
Data presented are number (%) of patients, unless otherwise indicated.
Cerebrovascular disease 5 previous cerebrovascular accident; COPD 5 chronic
obstructive pulmonary disease; Diabetes 5 diabetes requiring insulin or oral
agents; Heart failure 5 dyspnea, rales, chest radiographic changes of fluid or
dyspnea plus elevated wedge pressure; LVEF5 left ventricular ejection fraction;
MI 5 myocardial infarction; Peripheral vascular disease 5 peripheral vascular
operation; Prior CABG 5 at least one coronary artery bypass graft (CABG)
operation; Rest angina 5 symptoms at rest; Reversible ECG changes 5
electrocardiographic (ECG) T wave inversion on ST segment depression or
elevation that occurred with symptoms and were resolved with treatment;
Shock 5 altered mental status or reduced urinary output with blood pressure
,90 mm Hg and wedge pressure .18 mm Hg; Unstable angina 5 rest or
new-onset angina or increasing frequency of angina; 3-vessel 5 $70% lumen
narrowing of left anterior descending coronary artery and circumflex major
branch and posterior descending coronary artery.
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had angiographically successful PTCA (four patients with
shock died in low output state, and one septic patient died
from septic shock). The clinical success rate (angiographic
success plus no major complication) was 79% (102 of 131
patients).
Survival data. Survival was based on Kaplan-Meier esti-
mates. Table 4 presents longer term survival through 5 years.
Early mortality was derived from hospital records. Longer
term mortality was based on deaths recorded in the Beneficiary
Index Records Locator Subsystem data base. Mortality fell into
three periods: a very high period through 1 month, a high
period through 6 months and a low, stable period from 6
months through 5 years. Data are too sparse to estimate
survival beyond 5 years. Survival after 6 months is approxi-
mately exponential with an average annual survival of 97%.
Table 4 presents yearly survival estimates for patients who
survived at least 6 months after PTCA. These rates are
obtained by dividing the 1-, 2-, 3-, 4-, and 5-year survival rates
by the 6-month figure. These figures are compared with the
5-year survival (65 to 70 and 70 to 75 years) rates for the U.S.
population. Survival rates for the patients aged $70 years who
had PTCA and survived to 6 months are between the rates of
the 65 to 70-year age group and the 70 to 75-year age group.
The average annual survival rate for the 6-month survivors is
the same as that for the 65 to 70-year period for the U.S.
population (97%), and a bit higher than their census age
cohorts (95%).
Failed PTCA in an elderly high risk cohort. Table 5
presents clinical and angiographic data on the 28 patients in
whom PTCA failed in this series. Clinically, 21 (75%) of 28
experienced failure within 7 days of an acute infarction; 6
(21%) of 28 were in cardiogenic shock; 7 (25%) of 28 had
congestive heart failure before PTCA; 5 (18%) of 28 had a left
ventricular ejection fraction #0.35; and 5 (18%) of 28 were
taking pressor drugs. Anatomically, 17 (50%) of 34 vessels
attempted in this group were occlusions, and 16 (47%) of 34
vessels had an angiographic clot. In terms of outcomes, 3
(100%) of 3 cases complicated by distal embolization were
fatal; 2 (40%) of 5 acute occlusive syndromes in this cohort
were fatal; and the one “no-reflow” in this series was compli-
cated by a nonfatal infarction.
Discussion
This study reports on the outcomes of PTCA used to treat
medically resistant unstable angina in patients$70 years of age
in a logistically strained and conservative therapeutic environ-
ment. One significance of the environment is that patients who
will undergo PTCA for unstable angina in our hospital have
high prevalences of clinical and angiographic variables predic-
tive of adverse outcomes. Nevertheless, over 80% of the
patients at the Denver Veterans Affairs Medical Center aged
$70 years with unstable angina survived to 6 months after
PTCA. These results compare favorably with the short-term
Table 2. Angiographic Results of Coronary Angioplasty in Elderly
Patients With Unstable Angina
No. of Vessels*
No. of vessels attempted
1 (90 pts) 90
2 (39 pts) 78
3 (2 pts) 6
Total 174
Vessel attempted
LAD 49
Diag 10
Cx-OM 40
LMCA 9
RCA 37
SVG 29
Angiographic result
,50% (success) 150 (86%)
.50% residual stenosis (failure) 24 (14%)
*Can include tandem lesions or diffuse disease within one major coronary
artery. Cx-OM 5 circumflex coronary artery or obtuse marginal branch; Diag 5
diagonal branch of left anterior descending coronary artery; LAD5 left anterior
descending coronary artery; LMCA 5 left main coronary artery; pts 5 patients;
RCA 5 right coronary artery; SVG 5 saphenous vein graft.
Table 3. Short-Term Clinical Outcomes
Angiographic success 150/174 (86%)
Clinical success 102/131 (79%)
In-hospital deaths 15 (11%)
Emergency CABG 0
Urgent CABG 1 (,1%)
Hospital discharge 116 (89%)
Improvement in angina 116 (89%)
Data presented are number (%) of patients, unless otherwise indicated.
Angiographic success 5 ,50% diameter residual stenosis [number (%) of
vessels]; Clinical success 5 angiographic success in at least one artery plus relief
of angina plus no major complication (death, myocardial infarction, emergent or
urgent CABG); Emergency CABG5 coronary artery bypass graft surgery (CABG)
within 1 h of failed angioplasty; Hospital discharge5 discharge from index hospital
period; Improvement in angina 5 at least one Canadian Cardiovascular Society
class; Urgent CABG 5 CABG during same hospital period as angioplasty.
Table 4. Kaplan-Meier Survival Estimates for Denver High Risk
Patients Treated With Coronary Angioplasty for Unstable Angina
Time After PTCA
K-M Survival U.S. 5-yr Survival Rate
After
PTCA
(%)
6 mo
(%)
Age
65–70 yr
(%)
Age
70–75 yr
(%)
1 mo 87
6 mo 84 100 100 100
1 yr 81 97 98 97
2 yr 77 94 95 92
3 yr 77 89 92 87
4 yr 76 89 88 82
5 yr 74 87 85 78
Mean yearly survival
from mo 6 to yr 5*
97 97 95
*Estimated by linear regression of log(Kaplan-Meier [K-M] survival esti-
mate) on time. PTCA 5 percutaneous transluminal coronary angioplasty.
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predicted CABG survival rates in a cohort of sufficient risk,
nearly two-thirds of whom had been refused CABG. The
6-month survivors had a subsequent 5-year survival record that
was at least as good as that of the average population. These
results suggest that PTCA is a viable option for many elderly
patients with unstable angina who are at “high risk” and even
at “prohibitive risk” for surgical revascularization.
Bypass graft surgery in the elderly. A large number of
retrospective, consecutive case series support the use of CABG
in patients $70 years old. Most series report relief of symp-
toms in nearly 90% of patients, but all are in agreement that
short-term mortality is greater in patients $70 years old than
in younger patients (2–15). Within the entire population of
elderly patients with symptomatic ischemic disease, subsets
with recent infarction, hemodynamic compromise, severely
impaired left ventricular function, prior CABG, significant
comorbidity and diffuse coronary disease all have even higher
rates of mortality and morbidity; such patients are said to be at
“high risk” for CABG (15). At some level of risk, patients are
refused CABG based on the perception of “prohibitive risk”
Table 5. Clinical Failure of Attempted Coronary Angioplasty in 28 (21%) of 131 Elderly Patients With Unstable Angina
Pt No./
Age (yr) Clinical Setting
Comorbid
Disease CAD Clot
% Diam
Sten
Pre/Post
Intervention Outcome
In-Hospital Deaths (15 [11%] of 131)
1/74 MI, CHF, LVEF 0.25 Dementia LAD 3 95/100 MI
RCA 100/30
2/71 MI, shock, IABP, pressors LAD 3 70/30 24-h low CO
3/77 MI, shock, IABP, pressors LAD 3 100/50 24-h low CO
4/73 MI, shock, IABP, pressors LAD 3 100/100
RCA 3 100/100
5/73 MI, shock, IABP, post-CABG, renal LMCA 90/70 24-h low CO
Cx-OM 100/50
6/76 MI, CHF, shock, IABP, MI LAD 3 100/100
LAD 95/40
7/73 MI, hemodynamic, IABP, post-CABG, diabetes, renal Diag 3 95/100 2nd PTCA
8/76 MI, prior CABG, diabetes SVG-LAD 95/50 Embolization
9/70 MI LAD 3 100/50 Embolization
10/82 MI, CHF, prior CABG LAD 3 100/100
11/80 MI, CHF, prior CABG, COPD, renal SVG-LAD 95/60
12/80 AVR, sepsis, CHF, anemia, unstable angina Cx-OM 90/40 24-h sepsis
13/74 MI LAD 3 95/50 Embolization
14/72 LVEF 0.30, prior CABG, dialysis, PVD Cx-OM 3 95/95
15/70 MI, CHF, shock, pressors RCA 3 100/20 48-h low CO
Nonfatal Failures (13 [10%] of 131)
16/70 CVD/PVD RCA 90/100 Abrupt occlusion
17/74 MI, CHF, LVEF 0.29 Diabetes LAD 90/100 Abrupt occlusion
RCA 100/100
18/70 MI, LVEF 0.35 PVD, dialysis Cx-OM 100/100
19/74 MI, PVD, cancer RCA, cancer RCA 100/100
20/74 Prior CABG Syncope RCA 3 100/100
21/75 Diabetes Cx-OM 95/95
22/70 MI, LVEF 0.37 Alcohol RCA 90/100
23/75 RCA 3 100/100
24/77 Cx-OM 95/100
25/70 RCA 3 100/100
26/74 Prior CABG Cx-OM 100/100
RCA 100/100
27/70 MI, LVEF 0.35 Dialysis Cx-OM 100/100
28/78 MI, prior CABG Cancer SVG-RCA 3 95/40 No reflow
AVR 5 aortic valve replacement; CHF 5 congestive heart failure (tachypnea, rales, arterial desaturation, chest X-ray findings consistent with pulmonary edema);
Clot 5 angiographic clot; CO 5 cardiac output; CVD 5 cerebrovascular disease (surgery or stroke); Hemodynamic 5 hemodynamic compromised (blood pressure
,90 mm Hg systolic with pulmonary pressure wedge .12 mm Hg without shock signs); IABP 5 intraaortic balloon pump placed for hemodynamic reasons; pressors 5
dopamine, dobutamine; PVD 5 peripheral vascular disease (after operation); Pt 5 patient; renal 5 creatinine .2.0 mg/dl or dialysis required, or both; Shock 5
cardiogenic shock (includes blood pressure,80 m systolic with pulmonary wedge.18 and shock signs); % Diam Sten5 percent diameter stenosis; other abbreviations
as in Tables 1 and 2.
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(35). For selected “high risk” and “prohibitive risk” patients,
PTCA may be an alternative revascularization method (35,36).
Coronary angioplasty. A number of retrospective, consec-
utive case series support the use of PTCA for treating unstable
myocardial ischemia in patients$70 years old (16–37). Success
rates appear to be comparable to those obtained in patients
,70 years old, but reported incidences of complicating infarc-
tion, emergency CABG and hospital mortality are all higher
(16–37). Because these are series of selected patients, no
comparison between PTCA and CABG can be drawn from
these data.
We have been using PTCA to treat patients specifically
refused CABG (salvage angioplasty) for 8 years (39,40). Age
$70 years is a specific “high risk” factor from the Veterans
Affairs Surgical Registry, and accordingly, all 131 of these
patients were considered “high risk” for CABG; 82 (62%) of
the 131 patients had been specifically refused CABG by our
surgeons (15).
The use of PTCA as an alternative is being prospectively
tested in Veterans Affairs Cooperative 385—Angina With
Extremely Serious Operative Mortality Evaluation (AWE-
SOME). Patients who are accepted for CABG by surgeons at
the 14 participating hospitals are being randomized to either
CABG or PTCA, and patients refused CABG and patients
who refuse to be randomized are also being prospectively
followed in separate registries. From these data it will be
possible to identify specific cohorts for which PTCA or CABG
is preferable in terms of short- and long-term mortalities,
repeat revascularizations and symptoms.
Conclusions. The Denver Veterans Affairs PTCA experi-
ence with elderly, high risk patients with unstable angina
demonstrates the following: 1) The observed 30-day PTCA
survival rate of 87% compares favorably with a predicted
30-day CABG survival based on the Veterans Affairs Cardiac
Surgery Risk Assessment Model of 86%. 2) For those 84% of
elderly, high risk patients with unstable angina who survived 6
months after PTCA, their subsequent 1- to 5-year survival rates
are comparable to $70-year olds from the U.S. census. 3)
Previous CABG, which accords a high risk to $70-year olds
with unstable angina for repeat CABG, does not greatly
increase the risk for PTCA. 4) The highest risk factors in this
cohort for PTCA (shock, pressors on laboratory entry, prior
ventricular fibrillation and heart failure) were relatively infre-
quent. Accordingly, even if these factors were considered
“prohibitive risk,” most elderly patients with unstable angina
might be considered for the PTCA option.
We acknowledge the technical assistance of Charles Barbiere, CCRN, RCVT,
Rhonda Olmsted, CCRN and Randy Johnson, MS.
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